117 related articles for article (PubMed ID: 15762931)
1. Tuberculosis in allogeneic stem cell transplant recipients: still a problem in the 21st century.
Erdstein AA; Daas P; Bradstock KF; Robinson T; Hertzberg MS
Transpl Infect Dis; 2004 Dec; 6(4):142-6. PubMed ID: 15762931
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients.
Aljurf M; Gyger M; Alrajhi A; Sahovic E; Chaudhri N; Musa M; Ayoub O; Seth P; Aslam M; Al-Fiar F
Bone Marrow Transplant; 1999 Sep; 24(5):551-4. PubMed ID: 10482941
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis in blood and marrow transplant recipients.
Yuen KY; Woo PC
Hematol Oncol; 2002 Jun; 20(2):51-62. PubMed ID: 12111868
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis infection following renal transplantation in Taiwan.
Chen CH; Lian JD; Cheng CH; Wu MJ; Lee WC; Shu KH
Transpl Infect Dis; 2006 Sep; 8(3):148-56. PubMed ID: 16913973
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant infections: single center experience from the developing world.
Ullah K; Raza S; Ahmed P; Chaudhry QU; Satti TM; Ahmed S; Mirza SH; Akhtar F; Kamal K; Akhtar FM
Int J Infect Dis; 2008 Mar; 12(2):203-14. PubMed ID: 17920999
[TBL] [Abstract][Full Text] [Related]
8. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
9. Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome.
Yüksel M; Baron E; Camouse M; Cooper BW; Lazarus HM; Gerson SL; Laughlin MJ; Cooper KD; Gilliam A; Fu P; Stevens S; Koç ON
Biol Blood Marrow Transplant; 2006 Jun; 12(6):665-71. PubMed ID: 16737940
[TBL] [Abstract][Full Text] [Related]
10. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
Bradstock KF; Hertzberg MS; Kerridge IH; Svennilson J; McGurgan M; Huang G; Antonenas V; Gottlieb DJ
Intern Med J; 2006 Jun; 36(6):355-61. PubMed ID: 16732860
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis among allogeneic bone marrow transplant recipients in India.
George B; Mathews V; Srivastava V; Srivastava A; Chandy M
Bone Marrow Transplant; 2001 May; 27(9):973-5. PubMed ID: 11436108
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis in southern Chinese renal-transplant recipients.
Chen SY; Wang CX; Chen LZ; Fei JG; Deng SX; Qiu J; Li J; Chen GO; Fu HM; Xie CM
Clin Transplant; 2008; 22(6):780-4. PubMed ID: 19040560
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis in Thai renal transplant recipients: a 15-year experience.
Rungruanghiranya S; Ekpanyaskul C; Jirasiritum S; Nilthong C; Pipatpanawong K; Mavichak V
Transplant Proc; 2008 Sep; 40(7):2376-9. PubMed ID: 18790239
[TBL] [Abstract][Full Text] [Related]
15. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy by allogeneic stem cell transplantation.
Ringdén O
Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis infection in renal transplant recipients.
Ergun I; Ekmekci Y; Sengul S; Kutlay S; Dede F; Canbakan B; Erbay B
Transplant Proc; 2006 Jun; 38(5):1344-5. PubMed ID: 16797298
[TBL] [Abstract][Full Text] [Related]
18. Frequency of tuberculosis in haematological malignancies and stem cell transplant recipients.
Khan B; Ahmed P; Ullah K; Hussain CA; Hussain I; Raza S
J Coll Physicians Surg Pak; 2005 Jan; 15(1):30-3. PubMed ID: 15670521
[TBL] [Abstract][Full Text] [Related]
19. The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.
Kim SY; Lee DG; Kim MS; Kim HJ; Lee S; Min CK
Am J Hematol; 2008 Oct; 83(10):784-8. PubMed ID: 18661492
[TBL] [Abstract][Full Text] [Related]
20. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
